# Acadia Pharmaceuticals Inc: Form SCHEDULE 13D/A, filed Feb 26, 2026

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 18:59 ET
- Period: not reported
- Accession: 0001104659-26-020778
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000110465926020778/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000110465926020778/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000110465926020778/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-020778. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.